Keywords
Depressive Disorder ×
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

127 Search results.

Eligibility Unipolar Major Depressive Disorder NCT01875419

- 12/31/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Non-invasive Brain Stimulation and Cognitive Processing in Depression; ODM derived from: https://clinicaltrials.gov/show/NCT01875419

Efficacy and Safety of GSK163090 in Subjects with Major Depressive Disorder; NCT00896363 - Eligibility Question

- 10/29/19 - 1 form, 1 itemgroup, 3 items, 1 language
Itemgroup: Eligibility Determination
Study ID: 109035 Clinical Study ID: 109035 Study Title: A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of GSK163090 in Subjects With Major Depressive Disorder Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00896363 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK163090 1 mg, GSK163090 Placebo, GSK163090 3 mg Trade Name: Study Indication: Depressive Disorder

Eligibility Bipolar Depression NCT01284517

- 8/18/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression; ODM derived from: https://clinicaltrials.gov/show/NCT01284517

Eligibility Unipolar Depression NCT02401139

- 7/24/19 - 1 form, 1 itemgroup, 19 items, 1 language
Itemgroup: Criteria
Ketamine Trial for the Treatment of Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02401139

Eligibility Post-stroke Depression NCT02472613

- 6/13/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Acupuncture for Ischemic Post-stroke Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02472613

Maternal Depression in Home Visitation Treatment NCT01212783 - Eligibility Criteria

- 5/14/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Treatment of Maternal Depression in Home Visitation: Mother and Child Impacts; ODM derived from: https://clinicaltrials.gov/show/NCT01212783 Brief Summary: The purpose of this study is to determine the efficacy of In-Home Cognitive Behavioral Therapy (IH-CBT) in comparison to Present-Centered Therapy (PCT), a supportive therapeutic approach. IH-CBT is adapted form of CBT that is provided to depressed mothers participating in ongoing home visitation services. IH-CBT has been adapted to fit the setting, population, and context associated with home visiting. Mothers are recruited at 4 months postpartum. A comprehensive assessment battery is administered at pre-treatment, post-treatment, and 6, 12, and 18 months after the end of treatment. It is hypothesized that IH-CBT will be superior to PCT in decreasing depression, improving overall functioning, enhancing parenting effectiveness, and preventing relapse.

Eligibility Depressive Disorder NCT02498392

- 3/17/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress; ODM derived from: https://clinicaltrials.gov/show/NCT02498392

Eligibility Depressive Disorder NCT01916200

- 3/17/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01916200

Eligibility Depressive Disorder NCT02405715

- 3/17/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Therapy With an Oxytocin Adjunct for Major Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02405715

Eligibility Depression NCT02449499

- 3/16/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Adjunct Interpersonally Focused Psychodynamic Group Psychotherapy for Residual Depression Symptoms; ODM derived from: https://clinicaltrials.gov/show/NCT02449499

Eligibility Depression NCT02429674

- 3/16/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Efficacy of a Depression Intervention for Adolescents With Depression and Sleep Disturbances; ODM derived from: https://clinicaltrials.gov/show/NCT02429674

Eligibility Depression NCT02501239

- 3/16/19 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women; ODM derived from: https://clinicaltrials.gov/show/NCT02501239